Contract 47QSWA20D003R
Merakai, Llc · General Services Administration · January 21, 2020
Merakai, Llc was awarded a federal contract by General Services Administration (Federal Acquisition Service) on January 21, 2020 for an undisclosed amount of work in pharmaceutical preparation manufacturing. It was awarded under full and open competition. The contract has been modified 16 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on September 9, 2021. If all options are exercised, the contract could reach $500,000.
Contract details
- PIID
- 47QSWA20D003R
- Award type
- —
- Pricing
- Fixed Price With Economic Price Adjustment
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Chemical Analysis Instruments
- First action
- January 21, 2020
- Latest action
- September 9, 2021
Description
FEDERAL SUPPLY SCHEDULE CONTRACT
Modification timeline
-
September 9, 2021Mod PO0010$0
-
September 2, 2021Mod PSA834$0
-
July 22, 2021Mod PA0009$0
-
May 19, 2021Mod PA0008$0
-
May 19, 2021Mod PSA832$0
-
May 17, 2021Mod PA0007$0
-
November 11, 2020Mod PSA826$0
-
August 24, 2020Mod PSA824$0
-
June 10, 2020Mod PSA821$0
-
April 10, 2020Mod PO0006$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Leonardo Us Cyber And Security Solutions, Llc | General Services Administration | February 25, 2026 | $0 |
| Peeled Group Llc | General Services Administration | February 4, 2026 | $0 |
| Premier Biotech, Llc | General Services Administration | January 13, 2026 | $0 |
| Msab Incorporated | General Services Administration | September 8, 2021 | $0 |
| V & A Incorporated | General Services Administration | June 22, 2011 | $0 |
| Elginex Corp | General Services Administration | June 1, 2011 | $465 |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 53,729 | $99.76B |
| 2 | Pfizer Inc | 4,613 | $28.68B |
| 3 | Merck Sharp & Dohme Llc | 391 | $21.58B |
| 4 | Modernatx, Inc. | 3 | $8.20B |
| 5 | Sanofi Vaccines Us Inc. | 5,248 | $7.76B |
| 6 | Glaxosmithkline, Llc | 1,418 | $7.22B |
| 7 | Merck Sharp & Dohme Corp. | 349 | $5.33B |
| 8 | Pfizer Inc. | 3,842 | $4.83B |
| 9 | Eli Lilly And Company | 18 | $4.67B |
| 10 | Amerisourcebergen Drug Corp | 497 | $3.23B |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 47QSWA20D003R?
Contract 47QSWA20D003R is a federal contract awarded to Merakai, Llc by General Services Administration on January 21, 2020 for an undisclosed amount of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 16 times since the base award.
Who won contract 47QSWA20D003R?
Merakai, Llc won contract 47QSWA20D003R from General Services Administration.
How much is contract 47QSWA20D003R worth?
Contract 47QSWA20D003R has obligated $0 to date but carries a potential ceiling of $500,000 if fully funded and all options are exercised.